← Back
$ZNTL All transactions

Zentalis Pharmaceuticals, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$29K

Shares

21,000

Price

$1

Filed

Apr 30

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Myers Scott Dunseth

Title

CIK

0001356256

Roles

Director

Transaction Details

Transaction Date

2025-04-30

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

281,192

Filing Info

Accession No.

0001725160-25-000094

Form Type

4

Issuer CIK

0001725160

Myers Scott Dunseth's History

Date Ticker Type Value
2025-08-22 DVAX $41K
2025-06-17 ZNTL A $0
2025-06-11 DVAX A $0
2025-06-11 DVAX A $0
2025-04-30 ZNTL $29K

Other Insiders at ZNTL (90d)

No other insider activity at this issuer in the last 90 days.